Experience with cimetidine oral suspension formulation
Sparkman, H.E.
American Journal of Hospital Pharmacy 36(5): 600
1979
ISSN/ISBN: 0002-9289 PMID: 453211 Document Number: 153136
Document emailed within 1 workday
Related Documents
Degen, J.; Wölke, E.; Seiberling, M.; Thomann, P.; Völter-Erhardt, H. 1997: Comparison of the relative bioavailability and pharmacokinetics of estrone after oral administration of esterified estrogens in a tablet formulation and an aqueous suspension Arzneimittel-Forschung 47(2): 208-2122003: Sublingual selegiline: new formulation. New formulation: new risk of oral adverse effects Prescrire International 12(67): 179
Soni, S.D.; Tench, D.; Ashwood, T.J.; Movin, G. 1990: Pharmacokinetics of an oral controlled release formulation of remoxipride: a double-blind, crossover comparison with conventional formulation in chronic schizophrenics Acta Psychiatrica Scandinavica. Supplementum 358: 45-47
Alexander, K.S.; Thyagarajapuram, N. 2003: Formulation and accelerated stability studies for an extemporaneous suspension of amiodarone hydrochloride International Journal of Pharmaceutical Compounding 7(5): 389-393
Ullah, M.; Shah, M.R.; Bin Asad, M.H.H.; Hasan, S.M.F.; Hussain, I. 2017: Improved in vitro and in vivo performance of carbamazepine enabled by using a succinic acid cocrystal in a stable suspension formulation Pakistan Journal of Pharmaceutical Sciences 30(6): 2139-2145
Winkler, M.; Haller, G.; Oldhafer, K.; Bechstein, W.O.; Kattner, A.; Maibücher, A.; Färber, L.; Ringe, B.; Christians, U.; Neuhaus, P.; Pichlmayr, R. 1996: A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipients Transplantation 62(8): 1063-1068
Kuhnz, W.; al-Yacoub, G.; Fuhrmeister, A. 1992: Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation Contraception 46(5): 455-469
Yaqin, H.; Razvi, N. 1979: Oral cimetidine in duodenal ulceration Jpma. Journal of the Pakistan Medical Association 29(9): 184-188
Amsden, G.W.; Cheng, K.L.; Peloquin, C.A.; Nafziger, A.N. 1998: Oral cimetidine prolongs clarithromycin absorption Antimicrobial Agents and ChemoTherapy 42(7): 1578-1580
Szabo, K.A.; Schaff, E.A. 2013: Oral contraceptives: does formulation matter? Journal of Family Practice 62(10): E1-12
Unalp, A.; Uran, N.; Bayram, E.; Bayram, M.; Ozturk, A.A. 2008: Efficacy and safety of oral suspension of oxcarbazepine in children with epilepsy Neurosciences 13(4): 456-457
Bloomer, D.; Dupuis, L.L.; MacGregor, D.; Soldin, S.J. 1987: Palatability and relative bioavailability of an extemporaneous carbamazepine oral suspension Clinical Pharmacy 6(8): 646-649
Atkins, J.R.; Lull, M.E.; Decker, A.S.; Hutchinson, D.J. 2018: Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspension International Journal of Pharmaceutical Compounding 22(4): 326-328
Borisenko, K.K.; Glozman, V.N. 1974: Experience in using a zinc-corticotropin suspension in the therapy of certain dermatoses Vestnik Dermatologii i Venerologii 48(5): 78-80
Krahulec, P.; Rovný, F.; Matýsek, P.; Stanícek, J.; Chvátal, R. 1992: Personal experience with colpoureteral suspension using the Burch method Ceskoslovenska Gynekologie 57(5): 197-202
Batzer, F.R. 1984: Formulation and noncontraceptive uses of the new, low-dose oral contraceptive Journal of Reproductive Medicine 29(7 Suppl): 503-512
1985: WHO and UNICEF recommend new oral rehydration salts (ORS) formulation Bulletin of the Pan American Health Organization 19(1): 99-101
Holt, D.W.; Mueller, E.A.; Kovarik, J.M.; van Bree, J.B.; Richard, F.; Kutz, K. 1995: Sandimmun neoral pharmacokinetics: impact of the new oral formulation Transplantation Proceedings 27(1): 1434-1437
Waal-Manning, H.J.; Spears, G.F. 1978: Experience with a slow-release formulation of oxprenolol New Zealand Medical Journal 87(609): 245-246
Regan, P.T.; Malagelada, J.R.; DiMagno, E.P.; Go, V.L. 1978: Cimetidine as an adjunct to oral enzymes in the treatment of malabsorption due to pancreatic insufficiency Gastroenterology 74(2 Pt 2): 468-469